Clinical Trial: MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332182) titled 'MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee' on Jan. 07.

Brief Summary: The present study aims to compare the efficacy and the safety of MaioRegen Prime to Debridement (SSOC) in patients with deep osteochondral lesions of the knee joint. The foreseen population involves patients with osteochondral lesions with different etiology, dimension, shape, and location.

The evaluation will be performed through clinical, subjective and objective assessments.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Osteochondral Lesions of the Knee Joint Osteochondritis Dissecans (OCD) Early O...